← FDA Drug Approvals (Drugs@FDA)

AMLODIPINE BESYLATE AND VALSARTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS · Approved 2016-09-16

Drug application

FDA Application #
ANDA205137
Application type
Abbreviated New Drug Application (Generic)
Brand name
AMLODIPINE BESYLATE AND VALSARTAN
Generic name
Amlodipine Besylate
Active ingredients
AMLODIPINE BESYLATE; VALSARTAN
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
HETERO LABS
First approval
2016-09-16

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown